Power Law company profile

Generate Biomedicines

Biotech & Life Sciences · Somerville, United States · Founded 2020 · IPO 2026 Unicorn

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$2.04B

Market cap · Feb/2026

Revenue

$32M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $1B+ revenueColt · Power Law growth-stage

Pioneering Generative Biology to create breakthrough medicines

Investors

14 investors on Generate Biomedicines's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 14 investors entered at this stage

ARCH Venture Partners

Alaska Permanent Fund

Flagship Pioneering

MAPS Capital Management

Pictet

Fidelity Investments

Amgen

T. Rowe Price

Altitude Life Science Ventures

NVentures

Morningside

Samsung Life Science Fund

March Capital Partners

Abu Dhabi Investment Authority

Generate Biomedicines mafia

Startups founded by Generate Biomedicines alumni

Former Generate Biomedicines employees who went on to start their own companies. Sorted by Dealroom signal score.

Gate BioscienceEst. 2021

JMJordi Mata-FinkUnited States

Signal score79

Sana BiotechnologyEst. 2018

Geoffrey von MaltzahnUnited States

Signal score69

Apriori BioEst. 2020

Noubar AfeyanUnited States

Signal score66

Lila SciencesEst. 2024

JFJacob FealaUnited States

Signal score62

Book a demo to explore the full alumni network →

Global footprint

Where Generate Biomedicines has talent and traffic

AI talent share

8.0% of workforce is AI talent
(26 of 325 staff)

Core AI185.54%

Other AI82.46%

Non-AI workforce29992%

Workforce by country

5 countries with
team presence

🇺🇸 United States98.8%

🇦🇪 United Arab Emirates0.4%

🇬🇧 United Kingdom0.4%

🇨🇦 Canada0.4%

🇨🇳 China0.4%

5 countries shown

Web traffic by country

32K monthly visits
across markets

🇺🇸 United States59.4%

🇬🇧 United Kingdom22.2%

🇩🇪 Germany5.3%

🇨🇦 Canada2.5%

🇮🇳 India2.5%

Top 5 markets shown

Patent intelligence

$233k patent portfolio · 6 active families

Estimated portfolio value

$233k

0.01% of market cap · 32.6× smaller than top peer Sophia Genetics ($8M)

6 active patent families

Where Generate Biomedicines innovates BioinformaticsAntigen Binding FragmentViral infectionAntigen bindingVirology

Where Generate Biomedicines concentrates vs peers

Each axis is a top-10 topic across Generate Biomedicines and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Sentiment on X

What X is saying about Generate Biomedicines

An AI-synthesized read of the highest-engagement posts about Generate Biomedicines on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Generate Biomedicines on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles